Probiotics after antibiotic recovery sales will grow through 2036, led by gut health restoration at 60% of the application segment in 2026, driven by clinical recognition of antibiotic-associated microbiome disruption. The market was valued at USD 51.00 billion in 2025 and is expected to be worth USD 126.39 billion by 2036.